Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-03
DOI
10.3389/fphar.2021.629935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
- (2021) Shuai Wang et al. CELL RESEARCH
- Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections
- (2021) Chavan Sakshi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
- (2021) Cyrielle Fougeroux et al. Nature Communications
- Structure analysis of the receptor binding of 2019-nCoV
- (2020) Yun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Nervous system involvement after infection with COVID-19 and other coronaviruses
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Novel coronavirus and the central nervous system
- (2020) T. Sun et al. EUROPEAN JOURNAL OF NEUROLOGY
- Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19
- (2020) Masato Furuhashi et al. HYPERTENSION RESEARCH
- Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
- (2020) Hisashi Kai et al. HYPERTENSION RESEARCH
- An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
- (2020) Saurabh K. Sinha et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)
- (2020) Subhomoi Borkotoky et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
- (2020) Imane Abdelli et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
- (2020) Vipul Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Stilbene-based natural compounds as promising drug candidates against COVID-19
- (2020) Hussain Mustatab Wahedi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
- (2020) Sukanth Kumar Enmozhi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)
- (2020) Arno R. Bourgonje et al. JOURNAL OF PATHOLOGY
- ADAM17 inhibition may exert a protective effect on COVID-19
- (2020) Vanesa Palau et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
- (2020) Meng-Yuan Li et al. Infectious Diseases of Poverty
- Evaluation of the Inhibitory Activities of COVID‐19 of Melaleuca cajuputi Oil Using Docking Simulation
- (2020) Tran Thi Ai My et al. ChemistrySelect
- A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility
- (2020) Qiong Wang et al. VIROLOGICA SINICA
- Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil
- (2020) Bui Thi Phuong Thuy et al. ACS Omega
- Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction
- (2020) Gary Williamson et al. BIOCHEMICAL PHARMACOLOGY
- New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
- (2020) Yuhao Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
- (2020) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease
- (2020) Ahmed A. Daak et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach
- (2020) Rupesh V. Chikhale et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study
- (2020) Saurabh K. Sinha et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19
- (2020) Rupesh V. Chikhale et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach
- (2020) Xia Ren et al. JOURNAL OF ETHNOPHARMACOLOGY
- Potential of Flavonoid-Inspired Phytomedicines against COVID-19
- (2020) Wilfred Ngwa et al. MOLECULES
- Naringenin, a flavanone with antiviral and anti‐inflammatory effects: A promising treatment strategy against COVID ‐19
- (2020) Helda Tutunchi et al. PHYTOTHERAPY RESEARCH
- Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
- (2020) Rajaiah Alexpandi et al. Frontiers in Microbiology
- Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
- (2020) Vibhuti Kumar Shah et al. Frontiers in Immunology
- Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
- (2020) K. J. Senthil Kumar et al. Plants-Basel
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
- (2020) Ahmad Abu Turab Naqvi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Current pharmacological treatments for SARS-COV-2: A narrative review
- (2020) Giulio Nittari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Juan Manuel Gutierrez-Villagomez et al. Journal of Physical Chemistry Letters
- Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19
- (2020) Ahmed Rakib et al. MOLECULES
- Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV ‐2 drug targets: in vitro validation of furin inhibition
- (2020) I. Olaposi Omotuyi et al. PHYTOTHERAPY RESEARCH
- Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
- (2020) Anum Glasgow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
- (2020) Anamika Basu et al. Scientific Reports
- Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
- (2020) Kaewta Rattanapisit et al. Scientific Reports
- A historical perspective on ACE2 in the COVID-19 era
- (2020) Vivek Bhalla et al. JOURNAL OF HUMAN HYPERTENSION
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
- (2020) Thomas J. Esparza et al. Scientific Reports
- Egg White‐Derived Antihypertensive Peptide IRW (Ile‐Arg‐Trp) Reduces Blood Pressure in Spontaneously Hypertensive Rats via the ACE2/Ang (1‐7)/Mas Receptor Axis
- (2019) Wang Liao et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Peptide-based protease inhibitors from plants
- (2019) Roland Hellinger et al. DRUG DISCOVERY TODAY
- Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue
- (2019) Hui Liu et al. Evidence-based Complementary and Alternative Medicine
- Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods
- (2018) Aliyu Muhammad et al. BIOMEDICINE & PHARMACOTHERAPY
- Food-Derived Bioactive Peptides in Human Health: Challenges and Opportunities
- (2018) Subhadeep Chakrabarti et al. Nutrients
- Effects of IQP, VEP and Spirulina platensis hydrolysates on the local kidney renin angiotensin system in spontaneously hypertensive rats
- (2017) Jiahui Zheng et al. Molecular Medicine Reports
- Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1–7) Axis and Decreasing Inflammation Responses in Rats
- (2016) Yuewen Hao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Use of traditional medicine in middle-income countries: a WHO-SAGE study
- (2016) Oyinlola Oyebode et al. HEALTH POLICY AND PLANNING
- In Silico Discovery of Potential Uridine-Cytidine Kinase 2 Inhibitors from the Rhizome of Alpinia mutica
- (2016) Ibrahim Malami et al. MOLECULES
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor
- (2016) Lamei Yu et al. PEPTIDES
- Conservation and sustainable use of medicinal plants: problems, progress, and prospects
- (2016) Shi-Lin Chen et al. Chinese Medicine
- Baicalin attenuates angiotensin II-induced endothelial dysfunction
- (2015) Xiling Wei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
- (2015) Saori TAKAHASHI et al. BIOMEDICAL RESEARCH-TOKYO
- Medicinal plants: An invaluable, dwindling resource in sub-Saharan Africa
- (2015) Mack Moyo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Egg ovotransferrin-derived ACE inhibitory peptide IRW increases ACE2 but decreases proinflammatory genes expression in mesenteric artery of spontaneously hypertensive rats
- (2015) Kaustav Majumder et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Oral Delivery of ACE2/Ang-(1–7) Bioencapsulated in Plant Cells Protects against Experimental Uveitis and Autoimmune Uveoretinitis
- (2014) Pollob K Shil et al. MOLECULAR THERAPY
- The Discovery of the ACE2 Gene
- (2013) A.J. Marian CIRCULATION RESEARCH
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2
- (2013) Yun Shi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Transport of IRW, an Ovotransferrin-Derived Antihypertensive Peptide, in Human Intestinal Epithelial Caco-2 Cells
- (2013) Satyanarayana Bejjani et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Anti-inflammatory Effects of ω-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II–Dependent Hypertension
- (2013) Arzu Ulu et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Sequential C sp 3H Arylation and Olefination: Total Synthesis of the Proposed Structure of Pipercyclobutanamide A
- (2012) Will R. Gutekunst et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Stereoselective Preparation of Cyclobutanes with Four Different Substituents: Total Synthesis and Structural Revision of Pipercyclobutanamide A and Piperchabamide G
- (2012) Renhe Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nutraceuticals and botanicals: overview and perspectives
- (2012) Marcello Nicoletti INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Bioavailability of Bioactive Peptides
- (2011) Maira Segura-Campos et al. FOOD REVIEWS INTERNATIONAL
- Proprotein Convertase Inhibitory Activities of Flavonoids Isolated from Oroxylum Indicum
- (2010) S. Majumdar et al. CURRENT MEDICINAL CHEMISTRY
- The renin angiotensin system and the metabolic syndrome
- (2010) Annette D. de Kloet et al. PHYSIOLOGY & BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started